Idera founder Agrawal to retire next month

|About: Idera Pharmaceuticals,... (IDRA)|By:, SA News Editor

Idera Pharmaceuticals (NASDAQ:IDRA) announces that founder and President of Research Sudhir Agrawal, Ph.D., will retire on May 31 and will continue thereafter as a scientific advisor.

SVP and Head of Early Development Jonathan Yingling, Ph.D., will succeed him on an interim basis.